Status:
RECRUITING
Development of CIRC Technologies
Lead Sponsor:
The Cleveland Clinic
Conditions:
Cardiovascular Diseases
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial ...
Detailed Description
The primary clinical objective of the clinical study is to determine and compare cardiac microstructural phenotypes by cardiac MRI in patients and healthy controls and their relationship to cardiac st...
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years of age
- Provision of written informed consent
- If not healthy volunteer, must be diagnosed with cardiovascular disease
Exclusion Criteria:
- Vulnerable populations will be excluded from this study including Prisoners
- Other contraindications to CMR imaging to be determined by standard MRI protocols
- Decisionally impaired (e.g., dementia or cognitive disability)
Key Trial Info
Start Date :
September 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 9 2042
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05654272
Start Date
September 9 2022
End Date
September 9 2042
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Innovation Research Center
Cleveland, Ohio, United States, 44195